Tag: Pharmaceutical industry
Drugmakers’ Wish List: Meeting Trump’s Expectations in Healthcare
In a bold move that could potentially impact the entire pharmaceutical industry, Eli Lilly's CEO, Dave Ricks, recently announced plans to construct four manufacturing sites in the United States. This significant $27 billion investment...
Bill in Congress to Eliminate Small vs Large Molecule Drug Distinctions
In a recent development in Congress, lawmakers have put forth a bill aimed at amending a crucial aspect of the Inflation Reduction Act due to concerns that the current law is hindering investments in...
End of Novo Nordisk Ozempic and Wegovy Shortage
The Food and Drug Administration has officially announced the end of the shortage of Novo Nordisk’s popular drug semaglutide, a development that has significant implications for both patients and the pharmaceutical industry. This drug,...
Pfizer CEO Bourla’s Awkward Washington Encounter
Pfizer CEO Bourla's Awkward Washington EncounterBluebird Bio, a biotech company, recently made headlines by avoiding bankruptcy through a strategic sale to investment firms Carlyle and SK Capital. The deal, valued at less than $30...
Investigation Urged into Pharma Companies for Covid-19 Vaccine Claims
A U.K. Parliament member is urging regulators to investigate pharmaceutical companies for misleading claims about their Covid-19 vaccines. This call to action follows Moderna's reprimand by a U.K. trade group for its controversial recruitment...
California Democrats Debate Reining in Drug Industry Middlemen
The debate over reining in drug industry middlemen in California is heating up, with Governor Gavin Newsom and state legislators in Sacramento grappling with the high costs of prescription drugs. A recent proposal that...
Managing High Drug Costs: Strategies and Solutions
As the calendar flips to February 3, 2025, the latest episode of "An Arm and a Leg" delves into the pressing issue of managing high drug costs. Host Dan Weissmann sets the stage with...
Challenges of Accessing Effective Rare Disease Treatments
Cristina Brennan is facing a race against time. By the end of this year, her 12-year-old son Tristan will no longer have access to a crucial medicine that has been instrumental in managing his...
Prominent RFK Jr. Stands Firm Against Threatening Pharmaceutical Patents for Lower Drug Prices
Robert F. Kennedy Jr., former President Trump’s nominee for the position of Health and Human Services Secretary, made his stance clear during his Senate Finance Committee confirmation hearing in Washington. The discussion revolved around...
